Healthcare / Medical Care FacilitiesTSXV
$0.63
+0.04 (+6.78%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 27% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.7M · quality 42.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$35M
P/E
63.0x
↑EV/EBITDA
14.1x
↑ROE
-3.5%
↓Gross Margin
19.0%
↓Debt/Equity
0.64
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.6%
FCF CAGR
—
FCF margin
3.6%
FCF / Net income
-4.38x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $87.2M · net income $-717000.0 · FCF $3.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $87.2M | $87.2M | $72.8M | $66.1M | $62.7M |
| Net Income | $-717000.00 | $-717000.00 | $-728000.00 | $-107000.00 | $-4.1M |
| EBITDA | $3.1M | $3.1M | $3.0M | $3.6M | $-584000.00 |
| EPS | — | — | -0.01 | — | -0.09 |
| Gross Margin | 19.0% | 19.0% | 19.0% | 18.6% | 17.3% |
| Operating Margin | 2.3% | 2.3% | 1.9% | 0.7% | -2.0% |
| Net Margin | -0.8% | -0.8% | -1.0% | -0.2% | -6.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.64 | 0.64 | 0.53 | 0.55 | 0.65 |
| Current Ratio | 1.11 | 1.11 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $3.1M | $3.1M | $1.7M | $2.7M | $-934000.00 |
| Returns | |||||
| ROE | -3.5% | -3.5% | -3.4% | -0.5% | -19.0% |
| Valuation | |||||
| P/E | 63.00 | 63.00 | — | — | — |
| EV/EBITDA | 14.11 | 14.11 | 7.09 | 5.20 | — |
| P/B | 1.72 | 1.72 | 0.59 | 0.44 | 0.36 |
| Growth & Yield | |||||
| Revenue Growth | 19.8% | 19.8% | 10.1% | 5.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+125.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → n/d
Residual
+125.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.